Self‐efficacy mediates the effects of topiramate and GRIK1 genotype on drinking

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Addiction Biology

• Publication date

  2016-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/adb.12207PMID 25496338PMCID PMC4468044
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Self-efficacy mechanism in human agency

  2024cited by this paper
• GRIK1 genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink.

  2014cited by this paper
• Topiramate Treatment of Heavy Drinkers: Moderation by a GRIK1 Polymorphism

  2014cited by this paper
• CHANGES IN SELF‐EFFICACY AND OUTCOME EXPECTANCY AS PREDICTORS OF ANXIETY OUTCOMES FROM THE CALM STUDY

  2014cited by this paper
• Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.

  2014cited by this paper
• GRIK1 genotype and daily expectations of alcohol's positive effects moderate the reduction of heavy drinking by topiramate.

  2014cited by this paper
• Attributions of change and self-efficacy in a randomized controlled trial of medication and psychotherapy for problem drinking.

  2013influential reference
• Self-efficacy as a predictor of outcome after residential treatment programs for alcohol dependence: simply ask the patient one question!

  2013cited by this paper
• Motivation and self-efficacy in the context of moderated drinking: global self-report and ecological momentary assessment.

  2013cited by this paper
• Determining the relative importance of the mechanisms of behavior change within Alcoholics Anonymous: a multiple mediator analysis.

  2012cited by this paper
• Relationship of initial self-regulatory ability with changes in self-regulation and associated fruit and vegetable consumption in severely obese women initiating an exercise and nutrition treatment: moderation of mood and self-efficacy.

  2011cited by this paper
• The role of self-efficacy in the treatment of substance use disorders.

  2011cited by this paper
• Impact of motivational changes on drinking outcomes in pharmacobehavioral treatment for alcohol dependence.

  2011cited by this paper
• Self-efficacy change as a mediator of associations between therapeutic bond and one-year outcomes in treatments for alcohol dependence.

  2011cited by this paper
• Twelve-Step Facilitated Versus Mapping-Enhanced Cognitive-Behavioral Therapy for Pathological Gambling: A Controlled Study

  2011cited by this paper
• A general multilevel SEM framework for assessing multilevel mediation.

  2010cited by this paper
• VGLUT2 in dopamine neurons is required for psychostimulant-induced behavioral activation

  2009cited by this paper
• Measurement of admixture proportions and description of admixture structure in different U.S. populations

  2009cited by this paper
• Cue exposure in the treatment of alcohol dependence: effects on drinking outcome, craving and self-efficacy.

  2006cited by this paper
• Psychosocial Predictors of Treatment Outcome, Dropout, and Change Processes in a Pharmacological Clinical Trial for Alcohol Dependence

  2006cited by this paper
• Using daily interactive voice response technology to measure drinking and related behaviors in a pharmacotherapy study.

  2004cited by this paper
• Process and outcome changes with relapse prevention versus 12-Step aftercare programs for substance abusers.

  2002cited by this paper
• Evaluating substance abuse treatment process models: I. Changes on proximal outcome variables during 12-step and cognitive-behavioral treatment.

  1998cited by this paper
• Empirically based guidelines for moderate drinking: 1-year results from three studies with problem drinkers.

  1995cited by this paper
• The Drinker Inventory of Consequences (DrInC)

  1995cited by this paper
• Hierarchical Linear Models: Applications and Data Analysis Methods

  1992cited by this paper
• Timeline Follow-Back A Technique for Assessing Self-Reported Alcohol Consumption

  1992cited by this paper
• Self-efficacy: toward a unifying theory of behavioral change.

  1977cited by this paper
• Society for the Study of Addiction

  1977influential reference
• An inventory for measuring depression.

  1961cited by this paper

• Implications of genetic attributions for addiction in adults affected by alcohol use disorder and gambling disorder

  2025cites this paper
• From alcohol and other drug treatment mediator to mechanism to implementation: A systematic review and the cases of self-efficacy, social support, and craving.

  2024cites this paper
• Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review

  2022cites this paper
• Translational approach to understanding momentary factors associated with alcohol consumption

  2020cites this paper
• Stress-Associated Cognitive Functioning Is Controlled by Variations in Synaptic Plasticity Genes

  2020cites this paper
• Pharmacogenetics of alcohol addiction: current perspectives

  2019cites this paper
• Topiramate Pharmacotherapy for Alcohol Use Disorder and Other Addictions: A Narrative Review

  2019cites this paper
• Stellungnahme Dachgesellschaft Sucht:

  2019cites this paper
• Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years

  2018cites this paper
• Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment

  2018cites this paper
• Severe acute alcoholic hepatitis and liver transplant: A never-ending mournful story

  2018cites this paper
• Pharmacotherapy of alcoholism – an update on approved and off-label medications

  2017cites this paper
• Differential potassium channel gene regulation in BXD mice reveals novel targets for pharmacogenetic therapies to reduce heavy alcohol drinking.

  2017cites this paper
• Short title: Pharmacotherapy for alcohol dependence

  2017cites this paper
• Review article: pharmacotherapy for alcohol dependence – the why, the what and the wherefore

  2017cites this paper
• Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men.

  2017cites this paper
• Mechanisms of topiramate effects: refining medications development for alcoholism

  2016cites this paper
• Association study of DRD2 A2/A1, DRD3 Ser9Gly, DβH −1021C>T, OPRM1 A118G and GRIK1 rs2832407C>A polymorphisms with alcohol dependence

  2016cites this paper
• From genetic studies to precision medicine in alcohol dependence

  2016cites this paper
• Mechanisms of topiramate effects: refining medications development for alcoholism

  2016cites this paper
• Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients.

  2015cites this paper
• Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders.

  2015cites this paper
• Active Ingredients of Treatment and Client Mechanisms of Change in Behavioral Treatments for Alcohol Use Disorders: Progress 10 Years Later.

  2015cites this paper
• Mechanisms of topiramate effects: how and for whom does it work?

  2015cites this paper
• Anticonvulsants for the Treatment of Alcohol Withdrawal Syndrome and Alcohol Use Disorders

  2015cites this paper